Next-gen obesity biotech Metsera has filed to debut on the public markets, proposing an IPO nine months after emerging. | ...

Billionaire Warren Buffett has said many wise things over the past half a century, including a thing or two about dividend ...

The BBC investigates possible scenarios for the huge Arctic territory's future as the US president-elect talks about taking ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

These companies have track records of success, increasing dividends, and fantastic growth prospects, making them all ideal ...